FCGR3A and systemic lupus erythematosus: Furthermore, FCGR3A SNPs are clinically relevant in infections such as malaria, severe COVID-19, bacteremia in transplant patients, periodontitis, as well as in Kaposi’s sarcoma in HIV-infected patients and autoimmune diseases, including lupus and rheumatoid arthritis [21,40,41,42].